Successful combination therapy of systemic checkpoint inhibitors and intralesional interleukin-2 in patients with metastatic melanoma with primary therapeutic resistance to checkpoint inhibitors alone

David Rafei-Shamsabadi, Saskia Lehr, Dagmar von Bubnoff, Frank Meiss*

*Corresponding author for this work
10 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Successful combination therapy of systemic checkpoint inhibitors and intralesional interleukin-2 in patients with metastatic melanoma with primary therapeutic resistance to checkpoint inhibitors alone'. Together they form a unique fingerprint.

Medicine & Life Sciences